跳至主要内容
临床试验/CTRI/2024/08/072074
CTRI/2024/08/072074尚未招募不适用

Efficacy of ayurveda treatment protocol in the management of anovulation W.S.R follicular study. An open label clinical trial

Dr Chesta1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2024年12月2日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15
试验地点
1
主要终点
Follicular study

研究概览

简要总结

Anovulation is when the ovaries do not release a secondary oocyte during a menstrual cycle. Therefore, ovulation does not take place. Chronic anovulation is a common cause of infertility. Anovulation usually manifests itself as irregularity of menstrual periods, that is, unpredictable variability of intervals, duration, or bleeding. Anovulation can also cause cessation of periods (secondary amenorrhea) or excessive bleeding (dysfunctional uterine bleeding). The primary cause of infertility is anovulation accounting for 30% which frequently manifests as oligomenorrhea and amenorrhea. Ovarian factor contributes 30-40% of infertility cases among women. In modern science, various treatments are available for ovulation induction but all have unsatisfactory results and complications. So there is a great scope of research to find out safe potent remedy for the management of Anovulation. However, there is lack of specific treatment for anovulation, necessitating the development of a protocol that specifically addresses this issue. Due to above mentioned reasons and by understanding the impact of anovulation in women’s life an attempt is made to have effective ayurvedic treatment regime.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 30.00 Year(s)(—)
性别
Female

入选标准

  • A Married Women of age group of
  • 35 years. B Women who are diagnosed with anovulatory cycles. C Known case of PCOS with anovulatory cycles D Women who are willing to participate in the study.

排除标准

  • A A Known case of chronic systemic disorders (diabetes mellitus, hypertension, tuberculosis) and endocrinal disorders.
  • B H/o Any organic lesions of reproductive tract like tuberculosis, carcinoma and congenital deformities, or any other pelvic pathology.
  • C Known case of ovarian cyst.
  • D Patients suffering from adrenal hyperplasia, severe insulin resistance, androgen secreting neoplasm, thyroid abnormalities, Cushing’s syndrome, cardiac diseases will be excluded.

结局指标

主要结局

Follicular study

时间窗: Baseline | 2nd cycle | 3rd cycle

次要结局

  • Menstrual abnormalities (oligomenorrhea polymenorrhea(hypomennorhea))

研究者

发起方
Dr Chesta
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Chesta

KAHER shri BMK Ayurveda mahavidalaya Shahapur Belagavi

研究点 (1)

Loading locations...

相似试验